Skip to main content
Livermore
Livermore
ZHEN

Quadrant Capital Group LLC

SEC CIK
0001650717
Latest filing
Aug 14, 2026

CYTK holding history

Cytokinetics Inc in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings

Shares (Q2 2026)
15,533
Value
$1.32M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of CYTK by Quadrant Capital Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,533$1.32M<0.1%+167+1.1%AddedHolders
Q1 202615,366$1.01M<0.1%+670+4.6%AddedHolders
Q4 202514,696$933.8K<0.1%+5,448+58.9%AddedHolders
Q3 20259,248$508.3K<0.1%+9,248NewHolders
Q2 20250$00.0%−11,013−100.0%Sold outHolders
Q1 202511,013$442.6K<0.1%+7,330+199.0%AddedHolders
Q4 20243,683$173.2K<0.1%+31+0.8%AddedHolders
Q3 20243,652$192.8K<0.1%+271+8.0%AddedHolders
Q2 20243,381$183.2K<0.1%−668−16.5%ReducedHolders
Q1 20244,049$283.9K<0.1%+781+23.9%AddedHolders
Q4 20233,268$272.8K<0.1%+287+9.6%AddedHolders
Q3 20232,981$87.8K<0.1%+1,330+80.6%AddedHolders
Q2 20231,651$53.9K<0.1%+147+9.8%AddedHolders
Q1 20231,504$52.9K<0.1%−628−29.5%ReducedHolders
Q4 20222,132$97.7K<0.1%+173+8.8%AddedHolders
Q3 20221,959$95.0K<0.1%+1,596+439.7%AddedHolders
Q2 2022363$14.0K<0.1%+233+179.2%AddedHolders
Q1 2022130$5.00K<0.1%+63+94.0%AddedHolders
Q4 202167$3.00K<0.1%00.0%UnchangedHolders
Q3 202167$2.00K<0.1%+10+17.5%AddedHolders
Q2 202157$1.00K<0.1%00.0%UnchangedHolders
Q1 202157$1.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.